Modafinil is not a typical stimulant, but it provides stimulation, increases brain activity, increases self-reported measures of aggression, restlessness, and anxiety in double-blind testing, is a controlled substance with recognized abuse potential, and many of the stimulating effects are blocked by the same drugs that block the effects of stimulants.
Cephalon marketing is probably eager to get away and "stimulant" moniker, but this is an argument over semantics rather than pharmacology.
Modafinil is, by all measures and effects, a stimulant.